[1]
Jurkiewicz E.: Zastosowanie nowych technik rezonansu magnetycznego
w neurologii. [w:] Postępy w diagnostyce i leczeniu chorób układu nerwowego u dzieci. Tom 9. Jóźwiak S. [red.], Wyd. Bifolium, Lublin 2007.
[2]
Halwa S.: Fizyczne podstawy obrazowania w neuroradiologii, [w:] Neuroradiologia. J. Walecki (red.), Upowszechnianie Nauki – Oświata „UN-O”
Sp.zo.o., Warszawa 2000.
[3]
Lin A., Ross B., Harris K. et.al.: Efficacy of Proton Magnetic Resonance
Spectroscopy in Neurological Diagnosis and Neurotherapeutic Decision
Making. The Journal of the American Society for Experimental NeuroTherapeutics, 2005:2, 197–198.
[4]
Fix J.D.: Neuroprzekaźniki i szlaki nerwowe, [w:] Neuroanatomia. J. Moryś
(red.), J. Urban & Partner, Wyd. Med., Wrocław 1997.
[5]
Maheshwari S., Fatterpekar G., Castillo M., Mukherji K.: Proton MR spectroscopy of the brain. Seminars in Ultrasound, CT and MRI. W.B.Saunders
Company, Chapel Hill 2000.
[6]
Leutmezer F., Lurger S., Baumgartner Ch.: Focal features in patients with
idiopathic generalized epilepsy. Epilepsy Res., 2002:50, 293–300.
[7]
Serles W., Li L., Dubeau F. et al.: NAA/Cr is decreased in the temporal
lobes of patients with primary generalized epilepsy. Fourth International
Congress on Epilepsy, Florence 2000.
[8]
Hajek M., Dezortova M., Krsek P.: H MR spectroscopy in epilepsy. EJR,
2008; 67: 258–267.
[9]
Petroff O.A.C., Duncan J.S.: Magnetic resonance spectroscopy, [in:] Epilepsy a comprehensive textbook J. Engel, T. Pedley (red.), Lippincott
William&Wilkins, Philadelphia 2008.
[10]
Peeling J., Sutherland G.: 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex et hipocampus. Neurology, 1993:43,
589–594.
[11]
Petroff O.A.C., Errante L.S., Rothman D.L. et al.: Neuronal and glial metabolite kontent of the epileptogenic human hippocampus. Ann. Neurol.,
2002:52, 635–642.
[12]
Savic I., Österman Y., Helms G.: MRS shows syndrome differentiated
metabolite hanges in human- generalized epilepsies. Neuroimage,
2004:21, 163–172.
[13]
Savic I., Lekvall A., Greitz D. et al.: MR spectroscopy shows reduced
frontal lobe concentrations of N-acetyl aspartate in patients with juvenile
myoclonic epilepsy. Epilepsia, 2000:41, 290–296.
[14]
Mory S.B., Li L.M., Guerreiro C.A. et al.: Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study. Epilepsia, 2003:44, 1402–
1405.
[15]
Haki C., Gümüstas O.G., Bora I. et al.: Proton magnetic resonance spectroscopy study of bilateral thalamus in juvenile myoclonic epilepsy. Seizure, 2007:16(4), 287–295.
[16]
Fojtikova D., Brazdil M., Horky J. et al.: Magnetic resonance spectroscopy of the thalamus in patients with typical absence epilepsy. Seizure,
2006:15, 533–540.
[17]
Moore C., Wardrop M., Frederick B. et al.: Topiramat raises anterior
cingulate cortex glutamine levels in healthly men; 4,0 T magnetic resonance spectroscopy study. Psychopharmacology, 2006:188, 236–243.
[18]
Petroff O.A.C., Rothman D.L., Behar K.L. et al.: Human brain GABA levels
rise rapidly after initiation of vigabatrin therapy. Neurology, 1996:47(6),
1567–1571.
[19]
Petroff O.A.C., Rothman D.L., Behar K.L. et al.: Initial observations on
effect vigabatrin on in vivo 1Hspectroscopic measurements of γ-Aminobutyric Acid, Glutamate and Glutamine in human brain. Epilepsia,
1995:36, 457–464.
[20]
Hajek M., Dezortova M., Liscak R. et al.: H MR spectroscopy of mesial
temporal lobe epilepsies treated with gamma knife. EJR, 2003:13, 994–
1000.
Scholar Google
PubMed